Ellington Management Group’s Immunogen Inc IMGN Stock Holding History

Ellington Management Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18,900	Closed	-$179K	–	636
2018 Q3	$179K	Buy	+18,900	New	+$182K	0.05%	453
2018 Q2	–	Sell	-25,300	Closed	-$266K	–	919
2018 Q1	$266K	Buy	+25,300	New	+$250K	0.02%	636
2017 Q3	–	Sell	-79,100	Closed	-$562K	–	902
2017 Q2	$562K	Buy	+79,100	New	+$362K	0.08%	209
2015 Q3	–	Sell	-29,743	Closed	-$428K	–	939
2015 Q2	$428K	Sell	29,743 -52,857	-64%	-$581K	0.1%	295
2015 Q1	$739K	Buy	+82,600	New	+$598K	0.15%	176
2014 Q2	–	Sell	-26,000	Closed	-$388K	–	702
2014 Q1	$388K	Buy	+26,000	New	+$410K	0.11%	278

Other funds holding IMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ellington Management Group's IMGN Position: Q4 2018 in Review

Ellington Management Group sold out of Immunogen Inc (IMGN) in Q4 2018, closing a stake of 18,900 shares — an estimated $179K sold.

Ellington Management Group first reported a position in IMGN in Q1 2014 and held it in 6 quarters. The position peaked at $739K in Q1 2015. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2018.

Ellington Management Group reported no remaining Immunogen Inc position as of Q4 2018 after selling out during the quarter.
Ellington Management Group sold 18,900 Immunogen Inc shares in Q4 2018, an estimated $179K.
Ellington Management Group first reported a position in Immunogen Inc in Q1 2014 and held it in 6 quarters.
Ellington Management Group's Immunogen Inc position peaked at $739K in Q1 2015.
200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2018.

Based on Ellington Management Group's 13F filing for Q4 2018, filed 14 Feb 2019.